The National Institutes of Health (NIH) is offering a funding opportunity through the Coordinating Center for Type 1 Diabetes TrialNet (TNCC) aimed at supporting clinical trials focused on the prevention of type 1 diabetes (T1D) and the preservation of insulin production. This cooperative agreement, identified as RFA-DK-25-004, seeks to continue the existing project by facilitating a wide range of research activities, including data management and the selection of Clinical Centers, while emphasizing the importance of a Plan for Enhancing Diverse Perspectives (PEDP) to foster inclusivity in research. The funding amount is projected to reach approximately $29.5 million per year, with a maximum project duration of five years, and key deadlines include a letter of intent and full application submissions due by September 16, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-004.html.